Recent News

• 03.10.2025 - Q4 2024 Coherus BioSciences, Inc. Earnings Conference Call
• 03.10.2025 - Coherus BioSciences Reports Fourth Quarter, Full Year 2024 Financial Results and Provides Business Update
• 03.10.2025 - Coherus BioSciences Reports Fourth Quarter, Full Year 2024 Financial Results and Provides Business Update
• 03.04.2025 - 45th Annual TD Cowen Health Care Conference
• 03.04.2025 - 45th Annual TD Cowen Health Care Conference
• 03.03.2025 - Coherus to Report Fourth Quarter and Full Year 2024 Financial Results on March 10, 2025
• 03.03.2025 - Coherus to Report Fourth Quarter and Full Year 2024 Financial Results on March 10, 2025
• 02.24.2025 - Coherus Management to Participate at the 45th Annual TD Cowen Health Care Conference
• 02.24.2025 - Coherus Management to Participate at the 45th Annual TD Cowen Health Care Conference
• 01.22.2025 - Coherus Presents Final Phase 2 Clinical Casdozokitug Combination Data in Patients with Metastatic Hepatocellular Carcinoma at ASCO-GI 2025

Recent Filings

• 03.10.2025 - EX-99.1 EX-99.1
• 03.10.2025 - 8-K Current report
• 03.04.2025 - 8-K Current report
• 03.04.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 02.13.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.05.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.30.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 01.28.2025 - DEFM14A Definitive proxy statement relating to merger or acquisition
• 01.22.2025 - 4 Statement of changes in beneficial ownership of securities